Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells

Cancer Chemotherapy and Pharmacology

Volumn 37, Issue 5, 1996, Pages 457-462

  Parekh, Hemant ^a   Simpkins, Henry ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cisplatin resistance; Hypersensitivity; Mitotic spindle poisons

Indexed keywords

CISPLATIN; COLCHICINE; DEMECOLCINE; DOXORUBICIN; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; PACLITAXEL; VERAPAMIL; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT; BUTHIONINE SULFOXIMINE; DRUG DERIVATIVE; GLUTATHIONE; METHIONINE SULFOXIMINE; VINCA ALKALOID;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LYMPHOMA; MULTIDRUG RESISTANCE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; RAT; TUMOR CELL LINE; ANIMAL; CELL CULTURE; CELL SURVIVAL; DRUG EFFECT; DRUG RESISTANCE; FEMALE; METABOLISM; MITOSIS; OVARY TUMOR; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; BUTHIONINE SULFOXIMINE; CELL SURVIVAL; CISPLATIN; COLCHICINE; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; GLUTATHIONE; HUMANS; LYMPHOMA; METHIONINE SULFOXIMINE; MITOSIS; OVARIAN NEOPLASMS; P-GLYCOPROTEIN; PACLITAXEL; RATS; TUMOR CELLS, CULTURED; VERAPAMIL; VINCA ALKALOIDS;

EID: 0029664594     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050412     Document Type: Article

References (32)

1. Andrews PA, Murphy MP, Howell SB (1985) Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion. Cancer Res 45:6250
2. Andrews PA, Schiefer MA, Murphy MP, Howell SB (1988) Enhanced potentiation of cisplatin cytotoxicity in human ovarian carcinoma cells by prolonged glutathione depletion. ChemBiol Interact 65:51
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248
4. Campling BG, Baer K, Baker HM, Lam Y-M, Cole SPC (1993) Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines? Br J Cancer 68:327
5. Christen RD, Jekunen AP, Jones JA, Thiebaut F, Shalinsky DR, Howell SB (1993) In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules. J Clin Invest 92:431
6. Chu G (1994) Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. J Biol Chem 269:787
7. Clapper ML, Kuzmich S, Seestaller LM, Tew KD (1993) Time-course of glutathione S-transferase elevation in Walker mammary carcinoma cells following chlorambucil exposure. Biochem Pharmacol 45:683
8. Gately DP, Howell SB (1993) Cellular accumulation of the anticancer agent cisplatin. A review. Br J Cancer 67:1171
9. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC, Anderson ML (1992) High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 89:3070
10. Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385
11. Hamaguchi K, Godwin AK, Yakushiji M, O'Dwyer PJ, Ozols RF, Hamilton TC (1993) Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines. Cancer Res 53:5225
12. Hao X-Y, Bergh J, Brodin O, Hellman U, Mannervik B (1994) Acquired resistance to cisplatin and doxorubicin in a small cell lung cancer cell line is correlated to elevated expression of glutathione-linked detoxification enzymes. Carcinogenesis 15:1167
13. Harris AL, Hochhauser (1992) Mechanisms of multidrug resistance in cancer treatment. Acta Oncol 31:205
14. Isonishi S, Andrews PA, Howell SB (1990) Increased sensitivity to cis-diamminedichloroplatinum (II) in human ovarian carcinoma cells in response to treatment with 12-O-tetradecanoylphorhol 13-acetate. J Biol Chem 265:3623
15. Jekunen AP, Shalinsky DR, Hom DK, Albright KD, Heath D, Howell SB (1993) Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitro. Biochem Pharmacol 45:2079
16. Kawai K, Kamatani N, Georges E, Ling V (1990) Identification of a membrane glycoprotein overexpressed in marine lymphoma sublines resistant to cis-diamminedichloroplatinum (II). J Biol Chem 265:13137
17. Kelland LR (1994) The molecular basis of cisplatin sensitivity resistance. Eur J Cancer 30A:725
18. Kido Y, Khokhar AR, Siddik ZH (1994) Glutathione-mediated modulation of tetraplatin activity against sensitive and resistant tumor cells. Biochem Pharmacol 47:1635
19. Knox RJ, Lydall DA, Friedlos F, Basham C, Rawlings CJ, Roberts JJ (1991) The Walker 256 carcinoma:a cell type inherently sensitive to only those difunctional agents that can form DNA interstrand crosslinks. Mutat Res 255:227
20. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680
21. Mann SC, Andrews PA, Howell SB (1991) Modulation of cis-diamminedichloroplatinum (II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells. Int J Cancer 48:866
22. Mistry P, Loh SY, Kelland LR, Harrap KR (1993) Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines. Int J Cancer 55:848
23. Mossman T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55
24. Nakagawa K, Yokota J, Wada M, Sasaki Y, Fujiwara Y, Sakai M, Muramatsu M, Terasaki T, Tsunokawa Y, Terada M, Saijo N (1988) Levels of glutathione S-transferase pi mRNA in human lung cancer cell lines correlate with the resistance to cisplatin and carboplatin. Jpn J Cancer Res 79:301
25. Parekh H, Chitnis MP (1990) Evaluation of quinidine effect on the antitumor activity of adriamycin and mitoxantrone in adriamycin-sensitive and -resistant P388 leukemia cells. Selective Cancer Ther 6:93
26. 3 and its effect on cell survival of sensitive and resistant murine tumor cells. Anticancer Drugs 2:159
27. Raderer M, Scheithauer W (1993) Clinical trials of agents that reverse multidrug resistance. Cancer 72:3553
28. Scanlon KJ, Kashani-Sabet M, Tone T, Funato T (1992) Cisplatin resistance in human cancers. Pharmacol Ther 52:385
29. Sharma R, Singhal SS, Srivastava SK, Bajpai KK, Frenkel EP, Awasthi S (1993) Glutathione and glutathione linked enzymes in human small cell lung cancer cell lines. Cancer Lett 75:111
30. Simpkins H, Lehman JM, Mazurkiewicz JH, Davis BH (1991) A morphological and phenotypic analysis of Walker 256 cells. Cancer Res 51:1334
31. Tew KD (1994) Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 54:4313
32. Timmer-Bosscha H, Mulder NH, Vries EGF de (1992) Modulation of cis-diamminedichloroplatinum (II) resistance: a review. Br J Cancer 66:227